PerkinElmer Completes Acquisition of Antibody and Reagent Leader BioLegend

WALTHAM, Mass.–(BUSINESS WIRE)–Sep. 17, 2021– PerkinElmer, Inc. (NYSE: PKI) a global leader committed to innovating for a healthier world, today announced it has completed its acquisition of BioLegend, a leading, worldwide provider of life science antibodies and reagents for a total consideration of approximately $5.25 billion. The acquisition, the largest in PerkinElmer’s history, further expands the... Read more

NEW!!!! Glyphosate ELISA AOAC Test Kit for Durum Wheat, Whole Oats, Groats, Yellow Peas & Red Lentils

9/15/2021 Eurofins Abraxis is pleased to announce the launch of our Glyphosate AOAC ELISA Test Kit, (AOAC Cert. No. 072104) for the detection of Glyphosate in whole grain durum wheat, whole grain oats, oat groats, dried yellow peas, and dried red lentils. Eurofins Abraxis, a developer, manufacturer and supplier of test kits and systems for... Read more

IBM Research and Arctoris accelerate closed loop drug discovery with AI and Cloud

Oxford and Zurich – 13 September 2021 – Life Science Newswire – Today, IBM Research and Arctoris announced they are investigating the application of AI and automation to accelerate closed loop molecule discovery. IBM Research has developed RXN for Chemistry, an online platform leveraging state-of-the-art Natural Language Processing (NLP) architectures to automate synthetic chemistry. Representing chemical reactions via SMILES (Simplified Molecular... Read more

Quanterix Receives Label Expansion On Emergency Use Authorization For COVID Antigen Test

Simoa SARS-CoV-2 N Protein Antigen Test is first antigen test validated to detect all Variants of Concern currently designated by CDC, including Delta variant, and first authorized for use in saliva samples EUA label expansion demonstrates additional evidence showing potential for Simoa technology across range of clinical tests, including less-invasive testing BILLERICA, Mass., September 13,... Read more

The Intricate Network of Immune Cells Revealed by Multiplex Tissue Microscopy

When our immune systems identify invaders – such as parasites, bacteria or viruses – it can spark inflammation, which brings fluid and immune cells to the area of infection. While this can be very effective in battling infection, it also has collateral damage on nearby healthy tissues. In our daily lives, just by eating or... Read more

PerkinElmer Expands Automated Mycotoxin Detection Kits Portfolio to Include All Major Mycotoxins

New MaxSignal Mycotoxin Automation Bundle enables faster time to result, lower cost per sample and increased productivity WALTHAM, Mass. – August 19, 2021 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of its MaxSignal® Mycotoxin Automation Bundle. Using the new assays and automation of this bundle,... Read more

Pacific Biosciences Acquires Circulomics – A Leading High Molecular Weight DNA Extraction Company

MENLO PARK, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific Biosciences” or “PacBio”), a leading provider of high-quality, long-read sequencing platforms, announced today that it acquired Circulomics Inc. (“Circulomics”), a Maryland-based biotechnology company focused on delivering highly differentiated sample prep products that enable genomic workflows. Scientists recognize Circulomics... Read more

Tecan successfully completes the acquisition of Paramit

Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Männedorf, Switzerland, August 2 2021 – The Tecan Group (SIX Swiss Exchange: TECN) announced today that it has successfully completed the acquisition of US-based Paramit Corporation and its affiliates (“Paramit”) for a total purchase consideration of USD 1.0 billion (CHF 920 million). On June 23, 2021, Tecan... Read more

PerkinElmer to Acquire Antibody and Reagent Leader BioLegend

Transformative deal significantly scales leading position in life science to accelerate legendary discoveries in precision medicine Leader in antibody development with highly complementary, innovative portfolio in emerging, high-growth areas of biologics, cell and gene therapy, proteogenomics, and recombinant proteins Commercial synergy opportunity to accelerate life science growth with potential benefits for diagnostics franchise Annual BioLegend... Read more

PerkinElmer’s COVID-19 RT-PCR Test Kit Receives FDA Emergency Use Authorization for Saliva as Specimen Type

Non-invasive sampling method makes it easier to use the highly sensitive molecular test manufactured by PerkinElmer WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that the U.S. Food and Drug Administration (FDA) has authorized the PerkinElmer® New Coronavirus Nucleic Acid Detection Kit for an additional indication that permits... Read more